AAAAAA
Results: 1-25/27
Authors:
MARTINVILLALBA A
HERR I
JEREMIAS I
DEBATIN KM
HERDEGEN T
WINTER C
SCHENKEL J
ZIMMERMANN M
Citation: A. Martinvillalba et al., ISCHEMIA-INDUCED APOPTOSIS IN THE ADULT BRAIN CRITICALLY DEPENDS ON THE EXPRESSION OF CD95-L, TRAIL, TNF-ALPHA AND C-JUN, European journal of neuroscience, 10, 1998, pp. 1124-1124
Authors:
JEREMIAS I
HERR I
BOEHLER T
DEBATIN KM
Citation: I. Jeremias et al., TRAIL APO-2-LIGAND-INDUCED APOPTOSIS IN HUMAN T-CELLS/, European Journal of Immunology, 28(1), 1998, pp. 143-152
Authors:
JEREMIAS I
KUPATT C
BAUMANN B
HERR I
WIRTH T
DEBATIN KM
Citation: I. Jeremias et al., INHIBITION OF NUCLEAR FACTOR KAPPA-B ACTIVATION ATTENUATES APOPTOSIS RESISTANCE IN LYMPHOID-CELLS, Blood, 91(12), 1998, pp. 4624-4631
Authors:
BOHLER T
BAUMLER C
HERR I
GROLL A
KURZ M
DEBATIN KM
Citation: T. Bohler et al., ACTIVATION OF THE CD95 SYSTEM INCREASES WITH DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED CHILDREN AND ADOLESCENTS, The Pediatric infectious disease journal, 16(8), 1997, pp. 754-759
Authors:
ARTS J
HERR I
LANSINK M
ANGEL P
KOOISTRA T
Citation: J. Arts et al., CELL-TYPE-SPECIFIC DNA-PROTEIN INTERACTIONS AT THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR PROMOTER IN HUMAN ENDOTHELIAL AND HELA-CELLS IN-VIVO AND IN-VITRO, Nucleic acids research, 25(2), 1997, pp. 311-317
Authors:
DEBATIN KM
BELTINGER C
BOHLER T
FELLENBERG J
FRIESEN C
FULDA S
HERR I
LOS M
SCHEUERPFLUG C
SIEVERTS H
STAHNKE K
Citation: Km. Debatin et al., REGULATION OF APOPTOSIS THROUGH CD95 (APO-I FAS) RECEPTOR-LIGAND INTERACTION/, Biochemical Society transactions, 25(2), 1997, pp. 405-410
Authors:
HERR I
WILHELM D
BOHLER T
ANGEL P
DEBATIN KM
Citation: I. Herr et al., ACTIVATION OF CD95 (APO-1 FAS) SIGNALING BY CERAMIDE MEDIATES CANCER THERAPY-INDUCED APOPTOSIS/, EMBO journal, 16(20), 1997, pp. 6200-6208
Authors:
FULDA S
SIEVERTS H
FRIESEN C
HERR I
DEBATIN KM
Citation: S. Fulda et al., THE CD95 (APO-1 FAS) SYSTEM MEDIATES DRUG-INDUCED APOPTOSIS IN NEUROBLASTOMA-CELLS/, Cancer research, 57(17), 1997, pp. 3823-3829
Authors:
LOS M
HERR I
FRIESEN C
FULDA S
SCHULZEOSTHOFF K
DEBATIN KM
Citation: M. Los et al., CROSS-RESISTANCE OF CD95-INDUCED AND DRUG-INDUCED APOPTOSIS AS A CONSEQUENCE OF DEFICIENT ACTIVATION OF CASPASES (ICE CED-3 PROTEASES)/, Blood, 90(8), 1997, pp. 3118-3129
Authors:
BOHLER T
HERR I
DEBATIN KM
GEISS M
HAAS J
Citation: T. Bohler et al., DOWN-REGULATION OF INCREASED CD95 (APO-1 FAS) LIGAND IN T-CELLS FROM HUMAN IMMUNODEFICIENCY VIRUS-TYPE 1-INFECTED CHILDREN AFTER ANTIRETROVIRAL THERAPY/, Blood, 90(2), 1997, pp. 886-887
Authors:
BOHLER T
WALCHER J
HOLZLWENIG G
HERR I
DEBATIN KM
Citation: T. Bohler et al., SHORT-TERM EFFECT OF ANTIRETROVIRAL THERAPY ON DYSREGULATION OF THE CD95 (APO-1 FAS) SYSTEM AND T-CELL HOMEOSTASIS IN HIV-1-INFECTED CHILDREN AND ADOLESCENTS/, Blood, 90(10), 1997, pp. 581-581
Authors:
HERR I
BOHLER T
WILHELM D
ANGEL P
DEBATIN KM
Citation: I. Herr et al., ACTIVATION OF THE CD95 (APO-1 FAS) PATHWAY BY CERAMIDE MEDIATES RADIOTHERAPY AND CHEMOTHERAPY-INDUCED APOPTOSIS/, Blood, 90(10), 1997, pp. 1718-1718
Authors:
HERR I
BALEMANS L
BOHLER T
WALCZAK H
DEBATIN KM
Citation: I. Herr et al., MONITORING OF CD95 (APO-1 FAS) LIGAND EXPRESSION IN HUMAN T-CELLS BY QUANTITATIVE RT-PCR/, Cell death and differentiation, 3(3), 1996, pp. 299-305
Authors:
FRIESEN C
HERR I
KRAMMER PH
DEBATIN KM
Citation: C. Friesen et al., INVOLVEMENT OF THE CD95 (APO-1 FAS) RECEPTOR/LIGAND SYSTEM IN DRUG-INDUCED APOPTOSIS IN LEUKEMIA-CELLS/, Nature medicine, 2(5), 1996, pp. 574-577
Authors:
EHRET A
WESTENDORP MO
HERR I
DEBATIN KM
HEENEY JL
FRANK R
KRAMMER PH
Citation: A. Ehret et al., RESISTANCE OF CHIMPANZEE T-CELLS TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT-ENHANCED OXIDATIVE STRESS AND APOPTOSIS, Journal of virology, 70(9), 1996, pp. 6502-6507
Authors:
BAUMLER CB
BOHLER T
HERR I
BENNER A
KRAMMER PH
DEBATIN KM
Citation: Cb. Baumler et al., ACTIVATION OF THE CD95 (APO-1 FAS) SYSTEM IN T-CELLS FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED CHILDREN/, Blood, 88(5), 1996, pp. 1741-1746
Authors:
BOHLER T
HERR I
NEDEL S
HECKER S
DEBATIN KM
Citation: T. Bohler et al., INCREASED CD95 (APO-1 FAS) LIGAND IN T-CELLS FROM OLIGO-SYMPTOMATIC HIV-1-INFECTED CHILDREN - DOWN-REGULATION FOLLOWING ANTIRETROVIRAL THERAPY/, Blood, 88(10), 1996, pp. 1977-1977
Authors:
DEBATIN KM
FRIESEN C
HERR I
LOS M
Citation: Km. Debatin et al., ACTIVATION OF THE CD95 PATHWAY BY ANTICANCER DRUGS, Blood, 88(10), 1996, pp. 2641-2641
Authors:
JUNDT F
HERR I
ANGEL P
ZURHAUSEN H
BAUKNECHT T
Citation: F. Jundt et al., TRANSCRIPTIONAL CONTROL OF HUMAN PAPILLOMAVIRUS TYPE-18 ONCOGENE EXPRESSION IN DIFFERENT CELL-LINES - ROLE OF TRANSCRIPTION FACTOR YY1, Virus genes, 11(1), 1995, pp. 53-58
Authors:
SCHORPP M
MATTEI MG
HERR I
GACK S
SCHAPER J
ANGEL P
Citation: M. Schorpp et al., STRUCTURAL ORGANIZATION AND CHROMOSOMAL LOCALIZATION OF THE MOUSE COLLAGENASE TYPE-I GENE, Biochemical journal, 308, 1995, pp. 211-217
Authors:
VANDAM H
WILHELM D
HERR I
STEFFEN A
HERRLICH P
ANGEL P
Citation: H. Vandam et al., ATF-2 IS PREFERENTIALLY ACTIVATED BY STRESS-ACTIVATED PROTEIN-KINASESTO MEDIATE C-JUN INDUCTION IN RESPONSE TO GENOTOXIC AGENTS, EMBO journal, 14(8), 1995, pp. 1798-1811
Authors:
WILHELM D
VANDAM H
HERR I
BAUMANN B
HERRLICH P
ANGEL P
Citation: D. Wilhelm et al., BOTH ATF-2 AND C-JUN ARE PHOSPHORYLATED BY STRESS-ACTIVATED PROTEIN-KINASES IN RESPONSE TO UV IRRADIATION, Immunobiology, 193(2-4), 1995, pp. 143-148
Authors:
BAUKNECHT T
JUNDT F
HERR I
OEHLER T
DELIUS H
SHI Y
ANGEL P
ZURHAUSEN H
Citation: T. Bauknecht et al., A SWITCH REGION DETERMINES THE CELL-TYPE-SPECIFIC POSITIVE OR NEGATIVE ACTION OF YY1 ON THE ACTIVITY OF THE HUMAN PAPILLOMAVIRUS TYPE-18 PROMOTER, Journal of virology, 69(1), 1995, pp. 1-12
Authors:
HERR I
BALEMANS L
FRIESEN C
DEBATIN KM
Citation: I. Herr et al., DEVELOPMENT OF A QUANTITATIVE RT-PCR FOR THE HUMAN APO-1 (FAS CD95) LIGAND AND MONITORING OF LIGAND EXPRESSION IN NORMAL AND MALIGNANT T-CELLS/, Blood, 86(10), 1995, pp. 639-639
Authors:
DEBATIN KM
BAUMLER C
HERR I
STRICKER K
KNIPPING E
BOHLER T
KRAMMER PH
Citation: Km. Debatin et al., INVOLVEMENT OF THE APO-1 (FAS CD95) SYSTEM IN T-CELL DEPLETION IN AIDS/, Blood, 86(10), 1995, pp. 1139-1139